Erica Stone, Ph.D.
Vice President, Oncology
Dr. Stone is an award-winning immunologist with expertise in T cell immunology, immuno-oncology and human immunology. At GigaGen she leads immuno-oncology research and discovery of new first-in-class antibody therapies. Dr. Stone was most recently Assistant Professor in the Immunology, Microenvironment and Metastasis Program at The Wistar Institute Cancer Center where her independent laboratory focused on understanding the multiple mechanisms of action of first-generation immune checkpoint inhibitors, including anti-CTLA4, with the goal of identifying strategies to overcome resistance. She was awarded several grants for her research including the Melanoma Research Alliance’s Bristol-Myers Squibb-MRA Young Investigator Award and funding from the NIH. She also held the position Wistar Institute Assistant Professor of Pathology and Laboratory Medicine at the Perlman School of Medicine at the University of Pennsylvania where she was a member of the Institute for Immunology and the Immunology Graduate Group Executive Committee. Dr. Stone serves as Tumor Immunology Abstract Programming for the American Association of Immunology and was the 2017 recipient of AAI’s Chambers-Thermo Fisher Scientific Memorial Award. Dr. Stone is a sought-after speaker having recently presented at both SITC’s and AAI’s annual meetings, has published numerous manuscripts in journals including Immunity, Nature Reviews Immunology, Science, Clinical Cancer Research, ELife, and PNAS, mentored students and postdoctoral fellows, and served as a reviewer for many study sections and journals. Dr. Stone holds a B.S. in Biology summa cum laude from the University of New Hampshire and a Ph.D. in Biological Sciences from UC-San Diego where she also completed a postdoctoral fellowship in the Laboratory of Stephen Hedrick on the regulation of T helper cell differentiation and function by FOXO1.